Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000100

Director sold 797 shares at an average $26.13 ($20,827)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Greenleaf Peter Director 2026-07-02 Sale 10b5-1 −712 $26.00 $18,509 23,969 D: show line 1 in the form
Greenleaf Peter Director 2026-07-02 Sale 10b5-1 −85 $27.27 $2,318 23,884 D: show line 2 in the form
Open-market sales · 797 sh · avg $26.13 · $20,827
Loading xslF345X06/wk-form4_1783458198.xml…